This post discusses the financial performance of Meghmani Organics, RACL Geartech, and Kovai Medical Center & Hospital for the quarter ended 31 Dec. 2023 and their investment prospects considering these results. Meghmani Organics Meghmani Organics (MOL) reported its Q3FY24 (quarter ended 31 Dec. 2023) results on Jan. 30, 2024. This quarter's financial performance is a … Continue reading Analysis: Q3FY24 Results – II
This post discusses the financial performance of three stocks – Control Print, SRG Housing, and CSB Bank - for the quarter ended 31 Dec. 2023 and our perspective on the respective stocks’ investment prospects considering these results. Control Print Control Print reported its Q3FY24 results on Jan. 22, 2024. Sales and operating profit were up … Continue reading Analysis: Q3FY24 Results – I
The Disparity between Stock and Money Markets: A Cause for Concern This week was an eventful one. On Tuesday, the IMF in its Jan. 2024 World Economic Outlook (WEO) update, revised upward the world economic output growth to 3.1 percent – 20 basis points higher than projected in its Oct. 2023 outlook. India’s GDP growth … Continue reading Disparity in Markets
Evaluating the Investment Potential of RACL Geartech RACL Geartech would be one of the best investment decisions I have ever made, but one of my worst investment decisions too. I first purchased the stock at ₹67 per share in September 2018, which I consider one of my best investment decisions. But almost a year later, … Continue reading RACL Geartech’s Dream Run in the Stock Market
Control Print’s Recent Performance Analysis & Investment Stance Update Control Print has reported better earnings growth and profitability for the past two years. Its stock price performance over the past two years reflects this improved profitability. The stock has gained 17 percent in 2022 and 150 percent in 2023. We first discussed ‘Control Print’ in … Continue reading A Quality Stock, But at a Premium Valuation
Meghmani Organics' disappointing performance; challenges faced by the chemical industry; and positive initiatives for future growth. 8 Dec. 2023 Recap The stock performance of Meghmani Organics has been disappointing for investors in the past year. It experienced a loss of 32% in value, dropping from ₹111 to ₹75 per share. Over the last twelve months, … Continue reading Meghmani Organics: A Disappointing Year
The financial performance of CSB Bank for the quarter ended 30 Sep. 2023 has caught the attention of many investors and analysts. Despite a significant rise in Interest Income, the bank's net interest income has only slightly improved. The bank's cost-income ratio, which is the ratio of interest expense to interest income, has reached its … Continue reading CSB Bank Maintains its Competitive Position but Faces Impediments to Growth in the Near Term
11 October 2023 Kovai Medical Center & Hospital Sector: Healthcare CMP: ₹2,590 per share Market Cap.: ₹2,832 crores Kovai Medical Center & Hospital (KMCH) is a Coimbatore-based multi-specialty hospital which, as per the company statement - “since starting operations with 200 beds in 1990, has grown into a 2,250 bed multi-locational, multi-disciplinary super specialty hospital, … Continue reading Analysis – Kovai Medical Center & Hospital
Do you invest in the Stock Market? If not… You should… Because… your wealth has a significant role in determining the quality of your life… and the Stock Market is the greatest wealth creator of our times. Here, I share briefly what I know on… how to go about investing in the stock market… and, … Continue reading A Brief Intro. to the Stock Market
Deciding on “which stock to analyse” should be given serious consideration. The Indian market regular, SEBI, classifies listed Indian stocks - based on their market capitalisation - into three categories: large-cap stocks, mid-cap stocks, and small-cap stocks. Stocks ranked between 1 and 100 by market capitalisation are the ‘large caps’; those ranked between 101 and … Continue reading Selecting “Stocks to Analyse” Optimally
AMN CAPITAL 